+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

From
Alzheimer's Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Alzheimer's Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
From
From
From
From
From
Myasthenia Gravis Treatment Market: Forecast and Trends - Product Thumbnail Image

Myasthenia Gravis Treatment Market: Forecast and Trends

  • Report
  • November 2023
  • 120 Pages
  • Global
From
From
Fertility Drugs Market Report 2025 - Product Thumbnail Image

Fertility Drugs Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
From
Spinal Muscular Atrophy - Global Strategic Business Report - Product Thumbnail Image

Spinal Muscular Atrophy - Global Strategic Business Report

  • Report
  • May 2025
  • 189 Pages
  • Global
From
Intestinal Pseudo-Obstruction Treatment Market Report 2025 - Product Thumbnail Image

Intestinal Pseudo-Obstruction Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Companion Diagnostic Collaboration and Licensing Deals 2010-2024 - Product Thumbnail Image

Companion Diagnostic Collaboration and Licensing Deals 2010-2024

  • Report
  • November 2024
  • 300 Pages
  • Global
From
Loading Indicator